Alesta Therapeutics
Alesta Therapeutics is a biotechnology company developing novel oral small molecule therapies for rare diseases. Their lead asset, ALE1, targets hypophosphatasia, while ALE2 addresses Charcot-Marie-Tooth disease. The company aims to provide transformative treatments for patients with significant unmet needs in these areas.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: €65M
Date: 08-Jan-2025
Investors: Frazier Life Sciences, Droia Ventures, Novartis Venture Fund, RTW Investments, RV Invest, Thuja Capital, SSI Strategy
Markets: Biotechnology, Rare Diseases
HQ: Leiden, South Holland, Netherlands
Founded: 2021
Website: https://alestatherapeutics.com/
Leave a Comment
Comments
No comments yet.